At close: Apr 27, 16:00:00 GMT-4
Pre-market: Apr 28, 05:03:09 GMT-4
No Data Yet
Boehringer Ingelheim and Zealand Pharma's survodutide achieved 16.6% average weight loss in a Phase 3 trial, positioning it as a strong competitor in the obesity drug market.
The current price of Zealand Pharma A/S is $9.5, it has decreased 0% in the last trading day.
Zealand Pharma A/S's current market cap is $3.3B